Screening for diabetic retinopathy: new perspectives and challenges

Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, Peter H ORCID: 0000-0001-8513-710X, Peto, T. and Simó, R. (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes and Endocrinology, 8 (4). pp. 337-347. doi:10.1016/S2213-8587(19)30411-5

Full text not available from this repository.


Although the prevalence of all stages of diabetic retinopathy has been declining since 1980 in populations with improved diabetes control, the crude prevalence of visual impairment and blindness caused by diabetic retinopathy worldwide increased between 1990 and 2015, largely because of the increasing prevalence of type 2 diabetes, particularly in low-income and middle-income countries. Screening for diabetic retinopathy is essential to detect referable cases that need timely full ophthalmic examination and treatment to avoid permanent visual loss. In the past few years, personalised screening intervals that take into account several risk factors have been proposed, with good cost-effectiveness ratios. However, resources for nationwide screening programmes are scarce in many countries. New technologies, such as scanning confocal ophthalmology with ultrawide field imaging and handheld mobile devices, teleophthalmology for remote grading, and artificial intelligence for automated detection and classification of diabetic retinopathy, are changing screening strategies and improving cost-effectiveness. Additionally, emerging evidence suggests that retinal imaging could be useful for identifying individuals at risk of cardiovascular disease or cognitive impairment, which could expand the role of diabetic retinopathy screening beyond the prevention of sight-threatening disease. Vujosevic S1, Aldington SJ2, Silva P3, Hernández C4, Scanlon P2, Peto T5, Simó R6.

Item Type: Article
Article Type: Article
Uncontrolled Keywords: Retinopathy; Diabetes; Diabetes Control; Blindness; Screening
Subjects: R Medicine > RA Public aspects of medicine > RA645.A-Z Individual diseases or groups of diseases, A-Z > RA645.D54 Diabetes
R Medicine > RE Ophthalmology
Divisions: Schools and Research Institutes > School of Health and Social Care
Depositing User: Kate Greenaway
Date Deposited: 13 Mar 2020 09:47
Last Modified: 01 Aug 2021 21:50

University Staff: Request a correction | Repository Editors: Update this record

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter Google+ YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.